{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:11:52Z","timestamp":1767651112323,"version":"3.40.3"},"publisher-location":"Cham","reference-count":90,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030851088"},{"type":"electronic","value":"9783030851095"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-85109-5_5","type":"book-chapter","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T17:18:53Z","timestamp":1644254333000},"page":"73-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunological and Hematological Response in COVID-19"],"prefix":"10.1007","author":[{"given":"Artur","family":"S\u0142omka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Maria","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Giorgio","family":"Malvindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"\u017bekanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Suwalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Kowalewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"5_CR1","doi-asserted-by":"crossref","unstructured":"Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A, Martucci G, Pilz S, Malle O (2020) Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr","DOI":"10.1038\/s41430-020-0558-y"},{"key":"5_CR2","doi-asserted-by":"crossref","unstructured":"Arabi YM, Murthy S, Webb S (2020) COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med","DOI":"10.1007\/s00134-020-05955-1"},{"issue":"23","key":"5_CR3","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526\u20132533. https:\/\/doi.org\/10.1001\/jama.2012.5669","journal-title":"JAMA"},{"issue":"5","key":"5_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacbts.2020.04.002","volume":"5","author":"D Atri","year":"2020","unstructured":"Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA (2020) COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. [Published online ahead of print, 2020 Apr 10]. JACC Basic Transl Sci 5(5):518\u2013536","journal-title":"JACC Basic Transl Sci"},{"key":"5_CR5","doi-asserted-by":"crossref","unstructured":"Avula A, Nalleballe K, Narula N et al (2020) COVID-19 presenting as stroke. Brain Behav Immun. S0889-1591(20)30685-1","DOI":"10.1016\/j.bbi.2020.04.077"},{"issue":"6","key":"5_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(20)30084-4","volume":"5","author":"MN Bangash","year":"2020","unstructured":"Bangash MN, Patel J, Parekh D (2020) COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol 5(6):529\u2013530","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcrc.2017.09.012","volume":"43","author":"D Bar-Or","year":"2018","unstructured":"Bar-Or D, Carrick M, Tanner A, Lieser MJ, Rael LT, Brody E (2018) Overcoming the Warburg effect: is it the key to survival in sepsis? J Crit Care 43:197\u2013201","journal-title":"J Crit Care"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1172\/JCI117520","volume":"94","author":"M Basta","year":"1994","unstructured":"Basta M, Dalakas MC (1994) High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 94:1729\u20131735","journal-title":"J Clin Invest"},{"issue":"7","key":"5_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1055\/s-0032-1326782","volume":"38","author":"SM Bates","year":"2012","unstructured":"Bates SM (2012) D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 38(7):673\u2013682","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"5_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8):788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291","journal-title":"JAMA"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-020-09137-5","volume":"10","author":"D Birra","year":"2020","unstructured":"Birra D, Benucci M, Landolfi L, Merchionda A, Loi G, Amato P, Licata G, Quartuccio L, Triggiani M, Moscato P (2020) COVID 19: a clue from innate immunity. Immunol Res 10:1\u20138. https:\/\/doi.org\/10.1007\/s12026-020-09137-5","journal-title":"Immunol Res"},{"issue":"5","key":"5_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X (2020) COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 20(5):269\u2013270","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"5_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jama.2020.1623","volume":"323","author":"D Chang","year":"2020","unstructured":"Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA 323(11):1092\u20131093","journal-title":"JAMA"},{"issue":"10223","key":"5_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N et al (2020a) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"5_CR15","doi-asserted-by":"publisher","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q (2020b) Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI137244","DOI":"10.1172\/JCI137244"},{"issue":"5","key":"5_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829\u2013838","journal-title":"Kidney Int"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF (2017) Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 39:517\u2013528","journal-title":"Semin Immunopathol"},{"key":"5_CR18","doi-asserted-by":"crossref","unstructured":"Ciceri F et al (2020) Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. Online ahead of print","DOI":"10.51893\/2020.2.pov2"},{"key":"5_CR19","doi-asserted-by":"publisher","unstructured":"Cugno M et al (2020) Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.006. S0091-6749(20)30650-3","DOI":"10.1016\/j.jaci.2020.05.006"},{"key":"5_CR20","doi-asserted-by":"crossref","unstructured":"Cummings MJ et al (2020) Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. medRxiv. Apr 20:2020.04.15.20067157","DOI":"10.1016\/S0140-6736(20)31189-2"},{"key":"5_CR21","doi-asserted-by":"crossref","unstructured":"Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H et al (2020) Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection. medRxiv. 2020.03.04.20031120","DOI":"10.1101\/2020.03.04.20031120"},{"issue":"4","key":"5_CR22","first-page":"352","volume":"130","author":"R Flisiak","year":"2020","unstructured":"Flisiak R, Horban A, Jaroszewicz J, Kozielewicz D, Paw\u0142owska M, Parczewski M, Piekarska A, Simon K, Tomasiewicz K, Zar\u0119bska-Michaluk D (2020) Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med 130(4):352\u2013357","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"5_CR23","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","volume":"9","author":"SY Fung","year":"2020","unstructured":"Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY (2020) A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 9(1):558\u2013570","journal-title":"Emerg Microbes Infect"},{"key":"5_CR24","doi-asserted-by":"crossref","unstructured":"Gandhi A, Goerlinger K (n.d.) Coagulopathy in COVID-19: connecting the dots together. J Card Crit Care:TSS 2020. Online ahead of print","DOI":"10.1055\/s-0040-1712739"},{"issue":"3","key":"5_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1164\/ajrccm\/136.3.730","volume":"136","author":"L Gattinoni","year":"1987","unstructured":"Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M (1987) Pressure\u2013volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 136(3):730\u2013736","journal-title":"Am Rev Respir Dis"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-020-06103-5","volume":"25","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Meissner K, Marini JJ (2020a) The baby lung and the COVID-19 era. Intensive Care Med 25:1\u20133. https:\/\/doi.org\/10.1007\/s00134-020-06103-5","journal-title":"Intensive Care Med"},{"issue":"10","key":"5_CR27","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","volume":"201","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D (2020b) COVID-19 does not lead to a \u201cTypical\u201d acute respiratory distress syndrome. Am J Respir Crit Care Med 201(10):1299\u20131300. https:\/\/doi.org\/10.1164\/rccm.202003-0817LE","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13054-020-02880-z","volume":"24","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Chiumello D, Rossi S (2020c) COVID-19 pneumonia: ARDS or not? Crit Care 24(1):154. https:\/\/doi.org\/10.1186\/s13054-020-02880-z","journal-title":"Crit Care"},{"issue":"6","key":"5_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","volume":"46","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L (2020d) COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 46(6):1099\u20131102. https:\/\/doi.org\/10.1007\/s00134-020-06033-2","journal-title":"Intensive Care Med"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","volume":"9","author":"LE Gralinski","year":"2018","unstructured":"Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR et al (2018) Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9:e01753\u2013e01718","journal-title":"mBio"},{"key":"5_CR31","doi-asserted-by":"publisher","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"issue":"3","key":"5_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","volume":"11","author":"DC Hess","year":"2020","unstructured":"Hess DC, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Transl Stroke Res 11(3):322\u2013325","journal-title":"Transl Stroke Res"},{"issue":"10223","key":"5_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"issue":"3","key":"5_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","volume":"100","author":"HL Ji","year":"2020","unstructured":"Ji HL, Zhao R, Matalon S, Matthay MA (2020) Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 100(3):1065\u20131075","journal-title":"Physiol Rev"},{"issue":"5","key":"5_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jinf.2016.08.005","volume":"73","author":"JH Ko","year":"2016","unstructured":"Ko JH, Park GE, Lee JY, Lee JY, Cho SY, Ha YE, Kang CI, Kang JM, Kim YJ, Huh HJ, Ki CS, Jeong BH, Park J, Chung CR, Chung DR, Song JH, Peck KR (2016) Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Infect 73(5):468\u2013475","journal-title":"J Infect"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/jir.2011.0062","volume":"32","author":"A Kruttgen","year":"2012","unstructured":"Kruttgen A, Rose-John S (2012) Interleukin-6 in sepsis and capillary leakage syndrome. J Interferon Cytokine Res 32:60\u201365","journal-title":"J Interferon Cytokine Res"},{"key":"5_CR37","doi-asserted-by":"publisher","unstructured":"Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR (2020) Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. https:\/\/doi.org\/10.1016\/j.jmii.2020.02.012","DOI":"10.1016\/j.jmii.2020.02.012"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1086\/381535","volume":"189","author":"T Li","year":"2004","unstructured":"Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, Ma X, Fan H, Lu W, Xie J, Wang H, Deng G, Wang A (2004) Significant changes of peripheral t lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 189:648\u2013651","journal-title":"J Infect Dis"},{"issue":"1","key":"5_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"MY Li","year":"2020","unstructured":"Li MY, Li L, Zhang Y, Wang XS (2020a) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9(1):45","journal-title":"Infect Dis Poverty"},{"key":"5_CR40","doi-asserted-by":"publisher","unstructured":"Li Q, Ding X, Xia G, Geng Z, Chen F, Wang L, Wang Z (2020b) A simple laboratory parameter facilitates early identification of COVID-19 patients. medRxiv. https:\/\/doi.org\/10.1101\/2020.02.13.20022830","DOI":"10.1101\/2020.02.13.20022830"},{"key":"5_CR41","doi-asserted-by":"publisher","unstructured":"Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect:1\u201314. https:\/\/doi.org\/10.1080\/22221751.2020.1746199","DOI":"10.1080\/22221751.2020.1746199"},{"key":"5_CR42","doi-asserted-by":"publisher","unstructured":"Lippi G, Mattiuzzi C (2020) Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. https:\/\/doi.org\/10.1016\/j.htct.2020.03.001","DOI":"10.1016\/j.htct.2020.03.001"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145\u2013148","journal-title":"Clin Chim Acta"},{"key":"5_CR44","doi-asserted-by":"publisher","unstructured":"Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG (2020a) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). https:\/\/doi.org\/10.1097\/CM9.0000000000000744","DOI":"10.1097\/CM9.0000000000000744"},{"key":"5_CR45","doi-asserted-by":"publisher","unstructured":"Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020b) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv. https:\/\/doi.org\/10.1101\/2020.02.16.20023671","DOI":"10.1101\/2020.02.16.20023671"},{"key":"5_CR46","doi-asserted-by":"publisher","unstructured":"Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C et al (2020c) Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. medRxiv. https:\/\/doi.org\/10.1101\/2020.02.10.20021584","DOI":"10.1101\/2020.02.10.20021584"},{"issue":"6","key":"5_CR47","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apa.15270","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF (2020 Jun) Systematic review of covid-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109(6):1088\u20131095","journal-title":"Acta Paediatr"},{"key":"5_CR48","doi-asserted-by":"crossref","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in covid-19: a single center experience. J Med Virol","DOI":"10.1002\/jmv.25801"},{"key":"5_CR49","doi-asserted-by":"publisher","unstructured":"Marini JJ, Gattinoni L (2020) Management of COVID-19 respiratory distress. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.6825","DOI":"10.1001\/jama.2020.6825"},{"issue":"4","key":"5_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/1747493020923472","volume":"15","author":"HS Markus","year":"2020","unstructured":"Markus HS, Brainin M (2020) COVID-19 and stroke \u2013 a global World Stroke Organization perspective. Int J Stroke 15(4):361\u2013364","journal-title":"Int J Stroke"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"117808","DOI":"10.1016\/j.lfs.2020.117808","volume":"254","author":"VM Mart\u00edn Gim\u00e9nez","year":"2020","unstructured":"Mart\u00edn Gim\u00e9nez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, Manucha W (2020) Lungs as target of COVID-19 infection: protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci 254:117808. https:\/\/doi.org\/10.1016\/j.lfs.2020.117808","journal-title":"Life Sci"},{"key":"5_CR52","doi-asserted-by":"crossref","unstructured":"Martucci G, McNally D, Parekh D et al (2019) Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. 23:200","DOI":"10.1186\/s13054-019-2472-z"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) Hlh across speciality collaboration UK. Covid-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033\u20131034","journal-title":"Lancet"},{"key":"5_CR54","doi-asserted-by":"crossref","unstructured":"Michot JM, Albiges L, Chaput N, Saada V, Pommeret F, Griscelli F, Balleyguier C, Besse B, Marabelle A, Netzer F, Merad M, Robert C, Barlesi F, Gachot B, Stoclin A (2020) Tocilizumab, an anti-il6 receptor antibody, to treat covid-19-related respiratory failure: a case report. Ann Oncol","DOI":"10.1016\/j.annonc.2020.03.300"},{"key":"5_CR55","doi-asserted-by":"crossref","unstructured":"Muxel JM, Pires-Lapa MA, Morteiro AW, Cecon E, Tamura EK, Flaeten-Winter LM, Markus RP (2012) NF-kB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS One","DOI":"10.1371\/journal.pone.0052010"},{"key":"5_CR56","doi-asserted-by":"publisher","unstructured":"Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-A tough opponent for the immune system. Arch Med Res. https:\/\/doi.org\/10.1016\/j.arcmed.2020.05.020. May 30:S0188-4409(20)30749-9","DOI":"10.1016\/j.arcmed.2020.05.020"},{"issue":"19","key":"5_CR57","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1093\/eurheartj\/ehaa311","volume":"41","author":"L Nicin","year":"2020","unstructured":"Nicin L, Abplanalp WT, Mellentin H et al (2020) Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. Eur Heart J 41(19):1804\u20131806","journal-title":"Eur Heart J"},{"issue":"1","key":"5_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1258\/acb.2007.007167","volume":"45","author":"CA Northrop-Clewes","year":"2008","unstructured":"Northrop-Clewes CA (2008) Interpreting indicators of iron status during an acute phase response-lessons from malaria and human immunodeficiency virus. Ann Clin Biochem 45(1):18\u201332","journal-title":"Ann Clin Biochem"},{"issue":"20","key":"5_CR59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60","journal-title":"N Engl J Med"},{"issue":"6","key":"5_CR60","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","volume":"46","author":"XW Pan","year":"2020","unstructured":"Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG (2020) Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 46(6):1114\u20131116","journal-title":"Intensive Care Med"},{"key":"5_CR61","doi-asserted-by":"publisher","unstructured":"Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A (2020) Hypercoagulability of COVID-19 patients in intensive care unit. a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 17. https:\/\/doi.org\/10.1111\/jth.14850","DOI":"10.1111\/jth.14850"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.tmrv.2019.09.004","volume":"33","author":"CJ Patriquin","year":"2019","unstructured":"Patriquin CJ, Kuo KHM (2019) Eculizumab and beyond: the past, present, and future of complement therapeutics. Transfusion Med Rev 33:256\u2013265","journal-title":"Transfusion Med Rev"},{"key":"5_CR63","doi-asserted-by":"crossref","unstructured":"Piacente C, Martucci G, Miceli V, Pavone G, Papeo A, Occhipinti G, Panarello G, Lorusso R, Tanaka K, Arcadipane A (2020) A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: rationale, current use, effects on anticoagulation, and outcomes. Perfusion 267659120913803","DOI":"10.1177\/0267659120913803"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.medidd.2020.100044","volume":"6","author":"RJ Reiter","year":"2020","unstructured":"Reiter RJ et al (2020) Melatonin inhibits COVID-19-induced cytokine storm by reversing aerobic glycolysis in immune cells: a mechanistic analysis. Med Drug Discov 6:100044. https:\/\/doi.org\/10.1016\/j.medidd.2020.100044","journal-title":"Med Drug Discov"},{"key":"5_CR65","doi-asserted-by":"crossref","unstructured":"Shrestha GS et al (2020) Precision medicine for COVID-19: a call for better clinical trials. Crit Care","DOI":"10.1186\/s13054-020-03002-5"},{"key":"5_CR66","doi-asserted-by":"publisher","unstructured":"Song H, Seddighzadeh B, Cooperberg MR, Huang FW (2020) Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells [Published online ahead of print, 2020 May 6]. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2020.04.065","DOI":"10.1016\/j.eururo.2020.04.065"},{"issue":"6","key":"5_CR67","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/liv.14470","volume":"40","author":"J Sun","year":"2020","unstructured":"Sun J, Aghemo A, Forner A, Valenti L (2020) COVID-19 and liver disease. Liver Int 40(6):1278\u20131281","journal-title":"Liver Int"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","volume":"5","author":"L Tan","year":"2020","unstructured":"Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, Wang Q, Miao H (2020a) Lymphopenia predicts disease severity of covid-19: a descriptive and predictive study. Signal Transduct Target Ther 5:33","journal-title":"Signal Transduct Target Ther"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","volume":"5","author":"L Tan","year":"2020","unstructured":"Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ et al (2020b) Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 5:33. https:\/\/doi.org\/10.1038\/s41392-020-0148-4","journal-title":"Signal Transduct Target Ther"},{"key":"5_CR70","doi-asserted-by":"crossref","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020a) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost","DOI":"10.1111\/jth.14817"},{"key":"5_CR71","unstructured":"Tang X et al (2020b) Comparison of hospitalized patients with acute respiratory distress syndrome caused by covid-19 and h1n1. Chest"},{"issue":"4","key":"5_CR72","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020c) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844\u2013847","journal-title":"J Thromb Haemost"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 86:1327\u20131330","journal-title":"Thromb Haemost"},{"issue":"5","key":"5_CR74","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18(5):1023\u20131026","journal-title":"J Thromb Haemost"},{"issue":"9","key":"5_CR75","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1373\/clinchem.2011.166249","volume":"57","author":"A Tripodi","year":"2011","unstructured":"Tripodi A (2011) D-dimer testing in laboratory practice. Clin Chem 57(9):1256\u20131262","journal-title":"Clin Chem"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S1473-3099(07)70265-7","volume":"8","author":"T van der Poll","year":"2008","unstructured":"van der Poll T, Opal SM (2008) Host-pathogen interactions in sepsis. Lancet Infect Dis 8:32\u201343","journal-title":"Lancet Infect Dis"},{"key":"5_CR77","doi-asserted-by":"publisher","unstructured":"Wang J et al (2020a) Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. https:\/\/doi.org\/10.1002\/JLB.3COVR0520-272R","DOI":"10.1002\/JLB.3COVR0520-272R"},{"key":"5_CR78","doi-asserted-by":"publisher","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020b) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.1585","DOI":"10.1001\/jama.2020.1585"},{"key":"5_CR79","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"5_CR80","doi-asserted-by":"publisher","unstructured":"Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. https:\/\/doi.org\/10.1136\/bmj.m606","DOI":"10.1136\/bmj.m606"},{"issue":"7","key":"5_CR81","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1002\/jps.21167","volume":"97","author":"Z Yao","year":"2008","unstructured":"Yao Z, DuBois DC, Almon RR, Jusko WJ (2008) Pharmacokinetic\/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats. J Pharm Sci 97(7):2820\u20132832","journal-title":"J Pharm Sci"},{"issue":"6","key":"5_CR82","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect 80(6):607\u2013613","journal-title":"J Infect"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S (2020) COVID-19 pathophysiology: A review. Clin Immunol. 215:108427. https:\/\/doi.org\/10.1016\/j.clim.2020.108427","journal-title":"Clin Immunol."},{"issue":"4","key":"5_CR84","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020a) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586\u2013590","journal-title":"Intensive Care Med"},{"key":"5_CR85","doi-asserted-by":"crossref","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (2020b) The cytokine release syndrome (crs) of severe covid-19 and interleukin-6 receptor (il-6r) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 105954","DOI":"10.1016\/j.ijantimicag.2020.105954"},{"issue":"5","key":"5_CR86","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS (2020c) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 5(5):428\u2013430","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5_CR87","doi-asserted-by":"publisher","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD (2020d) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. https:\/\/doi.org\/10.1111\/all.14238","DOI":"10.1111\/all.14238"},{"key":"5_CR88","doi-asserted-by":"publisher","unstructured":"Zhang B, Zhou X, Zhu C, Feng F, Qiu Y, Feng J et al (2020e) Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. medRxiv. https:\/\/doi.org\/10.1101\/2020.03.12.20035048","DOI":"10.1101\/2020.03.12.20035048"},{"key":"5_CR89","doi-asserted-by":"publisher","unstructured":"Zhang H, Wang X, Fu Z, Luo M, Zhang Z, Zhang K et al (2020f) Potential factors for prediction of disease severity of COVID-19 patients. medRxiv. https:\/\/doi.org\/10.1101\/2020.03.20.20039818","DOI":"10.1101\/2020.03.20.20039818"},{"issue":"8","key":"5_CR90","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N et al (2020) A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"}],"container-title":["Advances in Experimental Medicine and Biology","Coronavirus Therapeutics \u2013 Volume I"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-85109-5_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T03:58:15Z","timestamp":1700193495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-85109-5_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030851088","9783030851095"],"references-count":90,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-85109-5_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"7 February 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}